| Primary |
| Drug Use For Unknown Indication |
20.5% |
| Dyspepsia |
16.7% |
| Premedication |
15.6% |
| Product Used For Unknown Indication |
12.6% |
| Gastrooesophageal Reflux Disease |
9.5% |
| Hypertension |
5.2% |
| Prophylaxis |
4.0% |
| Gastritis |
2.6% |
| Gastric Ulcer |
2.3% |
| Chemotherapy |
1.4% |
| Nausea |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Asthma |
1.0% |
| Ill-defined Disorder |
1.0% |
| Abdominal Pain |
0.9% |
| Duodenal Ulcer |
0.9% |
| Cardiomyopathy |
0.9% |
| Supplementation Therapy |
0.9% |
| Uterine Cancer |
0.8% |
| Abdominal Pain Upper |
0.8% |
|
| Drug Ineffective |
27.3% |
| Vomiting |
11.1% |
| Dyspepsia |
7.5% |
| Drug Screen Positive |
5.5% |
| Product Quality Issue |
4.9% |
| Rash |
4.5% |
| Urticaria |
4.3% |
| Overdose |
4.2% |
| Nausea |
3.9% |
| Shock |
3.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Pyrexia |
2.7% |
| Loss Of Consciousness |
2.5% |
| Drug Screen False Positive |
2.4% |
| Pruritus |
2.2% |
| Rhabdomyolysis |
2.2% |
| Diarrhoea |
2.1% |
| Medication Error |
2.1% |
| Malaise |
1.9% |
| Throat Irritation |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
13.3% |
| Drug Use For Unknown Indication |
12.0% |
| Hypertension |
11.3% |
| Gastrooesophageal Reflux Disease |
9.6% |
| Premedication |
8.9% |
| Dyspepsia |
7.4% |
| Prophylaxis |
4.9% |
| Foetal Exposure During Pregnancy |
3.6% |
| Breast Cancer |
3.4% |
| Cardiac Disorder |
3.0% |
| Diabetes Mellitus |
2.6% |
| Insomnia |
2.6% |
| Crohn's Disease |
2.4% |
| Migraine |
2.2% |
| Nausea |
2.2% |
| Renal Transplant |
2.2% |
| Anxiety |
2.2% |
| Chest Pain |
2.1% |
| Convulsion |
2.1% |
| Blood Cholesterol Increased |
1.8% |
|
| Vomiting |
20.6% |
| Drug Ineffective |
15.8% |
| Nausea |
11.0% |
| Drug Hypersensitivity |
4.0% |
| Dyspepsia |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Emphysema |
3.7% |
| Interstitial Lung Disease |
3.7% |
| Loss Of Consciousness |
3.7% |
| Wheezing |
3.7% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Diarrhoea |
2.6% |
| Grand Mal Convulsion |
2.6% |
| Intentional Drug Misuse |
2.6% |
| Malaise |
2.6% |
| Osteitis |
2.6% |
| Pneumonia |
2.6% |
| Stomach Discomfort |
2.6% |
| Weight Decreased |
2.6% |
| Amnesia |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Drug Use For Unknown Indication |
15.5% |
| Gastrooesophageal Reflux Disease |
7.7% |
| Hypertension |
6.6% |
| Pain |
6.0% |
| Prophylaxis |
5.3% |
| Rheumatoid Arthritis |
3.8% |
| Depression |
3.7% |
| Premedication |
3.6% |
| Asthma |
2.9% |
| Anxiety |
2.5% |
| Osteoporosis |
2.3% |
| Multiple Myeloma |
2.1% |
| Breast Cancer |
2.1% |
| Diabetes Mellitus |
1.9% |
| Dyspepsia |
1.7% |
| Nausea |
1.7% |
| Insomnia |
1.6% |
| Crohn's Disease |
1.6% |
| Constipation |
1.5% |
|
| Vomiting |
15.2% |
| Weight Decreased |
12.0% |
| Weight Increased |
6.8% |
| Nausea |
6.4% |
| White Blood Cell Count Decreased |
5.3% |
| Pain |
5.2% |
| Pyrexia |
4.7% |
| Drug Ineffective |
4.3% |
| Urinary Tract Infection |
4.2% |
| Pneumonia |
3.9% |
| Death |
3.7% |
| Pulmonary Embolism |
3.5% |
| Myocardial Infarction |
3.5% |
| Thrombocytopenia |
3.4% |
| Rash |
3.4% |
| Dyspnoea |
3.1% |
| White Blood Cell Count Increased |
3.0% |
| Renal Failure |
2.9% |
| Pruritus |
2.7% |
| Somnolence |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
37.5% |
| Product Used For Unknown Indication |
22.5% |
| Lower Respiratory Tract Infection |
15.0% |
| Adrenogenital Syndrome |
2.5% |
| Antacid Therapy |
2.5% |
| Chronic Myeloid Leukaemia |
2.5% |
| Dyspepsia |
2.5% |
| Erectile Dysfunction |
2.5% |
| Multiple Myeloma |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.5% |
| Smoking Cessation Therapy |
2.5% |
| Ulcer |
2.5% |
| Vomiting |
2.5% |
|
| Gastrooesophageal Reflux Disease |
25.0% |
| Drug Interaction |
16.7% |
| Vomiting |
16.7% |
| Hypercalcaemia |
8.3% |
| Infusion Site Extravasation |
8.3% |
| Nephropathy Toxic |
8.3% |
| Pancreatitis |
8.3% |
| Visual Impairment |
8.3% |
|
